Cargando…
Reduction of Circulating Endothelial Cells in Peripheral Blood of ALS Patients
BACKGROUND: Amyotrophic Lateral Sclerosis (ALS) treatment is complicated by the various mechanisms underlying motor neuron degeneration. Recent studies showed that the blood-brain barrier (BBB) and blood-spinal cord barrier (BSCB) are compromised in an animal model of ALS due to endothelial cell deg...
Autores principales: | Garbuzova-Davis, Svitlana, Woods, Robert L., Louis, Michael K., Zesiewicz, Theresa A., Kuzmin-Nichols, Nicole, Sullivan, Kelly L., Miller, Amber M., Hernandez-Ontiveros, Diana G., Sanberg, Paul R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868893/ https://www.ncbi.nlm.nih.gov/pubmed/20485543 http://dx.doi.org/10.1371/journal.pone.0010614 |
Ejemplares similares
-
Humoral factors in ALS patients during disease progression
por: Ehrhart, Jared, et al.
Publicado: (2015) -
Blood-CNS Barrier Impairment in ALS patients versus an animal model
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2014) -
Human Umbilical Cord Blood Treatment in a Mouse Model of ALS: Optimization of Cell Dose
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2008) -
Multiple Intravenous Administrations of Human Umbilical Cord Blood Cells Benefit in a Mouse Model of ALS
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2012) -
Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2018)